Defining localities of inadequate treatment for childhood asthma: A GIS approach by Peled, Ronit et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
International Journal of Health 
Geographics
Open Access Research
Defining localities of inadequate treatment for childhood asthma: A 
GIS approach
Ronit Peled*1, Haim Reuveni1,2, Joseph S Pliskin1,3, Itzhak Benenson4, 
Erez Hatna4 and Asher Tal2
Address: 1Department of Health Systems Management, Ben-Gurion University of the Negev, Beer-Sheva, Israel, 2Pediatrics Department, Soroka 
University Medical Center, Beer-Sheva Israel, 3Department of Industrial Engineering and Management, Ben-Gurion University of the Negev, Beer-
Sheva, Israel and 4Department of Geography, Tel Aviv University, Tel Aviv, Israel
Email: Ronit Peled* - ronitpeled@yahoo.com; Haim Reuveni - reuveni1@bgumail.bgu.ac.il; Joseph S Pliskin - jpliskin@bgumail.bgu.ac.il; 
Itzhak Benenson - bennya@post.tau.ac.il; Erez Hatna - erezh51@tau.ac.il; Asher Tal - ashik@bgumail.bgu.ac.il
* Corresponding author    
Abstract
Background: The use of Geographic Information Systems (GIS) has great potential for the management of
chronic disease and the analysis of clinical and administrative health care data. Asthma is a chronic disease
associated with substantial morbidity, mortality, and health care use. Epidemiologic data from all over the world
show an increasing prevalence of asthma morbidity and mortality despite the availability of effective treatment.
These facts led to the emergence of strategies developed to improve the quality of asthma care.
The objective: To develop an efficient tool for quality assurance and chronic disease management using a
Geographic Information System (GIS).
Geographic location: The southern region of Israel. January 1998 – October 2000.
Databases: Administrative claims data of the largest HMO in Israel: drug dispensing registry, demographic data,
Emergency Room visits, and hospitalization data bases.
Methods: We created a list of six markers for inadequate pharmaceutical treatment of childhood asthma from
the Israeli clinical guidelines. We used this list to search the drug dispensing registry to identify asthmatic children
who received inadequate treatment and to assess their health care utilization and bad outcomes: emergency room
visits and hospitalizations. Using GIS we created thematic maps on which we located the clinics with a high
percentage of children for whom the treatment provided was not in adherence with the clinical guidelines.
Results: 81% of the children were found to have at least one marker for inadequate treatment; 17.5% were found
to have more than one marker. Children with markers were found to have statistically significant higher rates of
Emergency Room visits, hospitalizations and longer length of stay in hospital compared with children without
markers. The maps show in a robust way which clinics provided treatment not in accord with the clinical
guidelines. Those clinics have high rates of Emergency Room visits, hospitalizations and length of stay.
Conclusion: Integration of clinical guidelines, administrative data and GIS can create an efficient interface
between administrative and clinical information. This tool can be used for allocating sites for quality assurance
interventions.
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Introduction
GIS
The use of information technologies such as the Geo-
graphic Information Systems (GIS) has great potential for
the management of chronic disease and the analysis of
clinical and administrative health care data.
Geographic mapping of health phenomena has been well-
known since the dot maps created by Snow in 1855 which
allocated cholera outbreaks in London, England. In the
last decades, the use of geographic mapping has been
expanded especially since the development of GIS tech-
nologies which comprise data analysis through spatial
strategies and a visual presentation of the information [1-
3]. The impact of GIS has been widely felt in all fields that
use geographic information – resource management [4],
land-use planning [5], pollution [6-8], transportation and
utilities, marketing, geosciences and planning of health
care facilities[9,10].
Burrough [11] identified five basic functional compo-
nents in GIS: (1) data acquisition and data verification;
(2) data storage and database management; (3) data
transformation and analysis; (4) data output and presen-
tation; and (5) user interface.
One of the more powerful features of GIS is the ability to
link several data bases such as demographic, clinical, and
billing systems, and create a high resolution demonstra-
tion of the spatial distribution and or behavior of the phe-
nomenon. Therefore, the use of GIS in health related
studies is emerging as an important tool in health care
planning, quality assurance, and research.
GIS was used by researchers to analyze spatial patterns of
cancer mortality in China [12], identifying high levels of
lead exposure in children [13], defining localities for the
management of primary health care in England [14],
mapping and analyzing rates and distribution of child
abuse in order to allocate special services [15]as well as
many other applications.
Asthma
The epidemiology of asthma has drawn much attention in
the past two decades since data from the United States, as
well as from around the world, showed an increasing
prevalence of asthma morbidity and mortality despite the
availability of effective treatment [16]. Asthma is a chronic
disease associated with substantial morbidity, mortality,
and health care use. Between 1980 and 1994, the self-
reported prevalence of asthma increased 75% among all
race, sex, and age groups in every region of the United
States. Although an estimated 14.6 million persons had
asthma in the United States in 1996, more recent studies
have suggested a plateau of the prevalence of the disease
[17]. Asthma is recognized nowadays as the most com-
mon chronic disease for children and adults and has
become an economic burden to patients, their families,
health care providers, and society.
Epidemiologic literature on asthma describes large geo-
graphic variations in asthma outcomes [18,19]. These var-
iations were found among states [19], among counties
within states [20], among cities [18]and even among
neighborhoods within cities [21]. These studies raised
important questions as to the role that quality of health
care plays in contributing to these geographic variations.
Understanding the link between quality of care and poor
clinical outcomes for asthma patients led to the emer-
gence of strategies developed to improve the quality of
asthma care.
Clinical guidelines and quality of care
Although there are many ways to approach quality of care
improvement, most of them fall into two general areas:
professional knowledge relating to diagnosis and treat-
ment, and knowledge for improvement related to the
design of the delivery of care [22]. The professional
knowledge is presented in clinical guidelines for asthma
treatment, which are a summary of clinical evidence and
expert opinion. These clinical guidelines can play a major
role in the quality improvement process and in the design
of the delivery of care. Thus, an adequate implementation
of the clinical guidelines became crucial for health care
organizations who maintain a quality assurance process,
since it was well documented that patients who received
treatment in adherence to the clinical guidelines achieved
the treatment goals [23,24].
Table 1: Markers for inadequate treatment of asthma
Marker Number Description
1 More than 55 days of relievers' treatment without treatment with controllers.
2 Dispensation of more than one long-acting agonist with no other treatment.
3 High frequency of drug treatment changes.
4 More than 15 dispensations of controllers per year (excluding antileukotriene).
5 High ratio of reliever to controller prescriptions.
6 More than 30 tablets of Beta-agonist per year.International Journal of Health Geographics 2006, 5:3 http://www.ij-healthgeographics.com/content/5/1/3
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The objective
The objective of this study was to develop a tool, using GIS
technology, to locate inappropriate treatment and poor
treatment outcomes for children with asthma, as a result
of inadequate implementation of the clinical guidelines.
We hypothesized that in a world of high quality compu-
terized data, such a tool could be useful for decision anal-
ysis while planning health care delivery and maintaining
quality assurance procedures.
Methods
Geographic location
The study was conducted in the southern region of Israel
using data sets of Clalit Health Services (CHS), the largest
HMO in Israel, through which 770,000 members, includ-
ing 143,000 infants, are insured.
Study period
January 1998 – October 2000.
Information sources
We used the three parts of the CHS claims data sets: 1.
Drug dispensing registry which included patient ID, name
and serial number of the drug dispensed and date of dis-
pensing; 2. Demographic data which included: ID, date of
birth, address, name and address of affiliated clinic; 3.
Health care utilization data sets which included: Emer-
gency Room (ER) visits to pediatric and internal medicine
ER wards; and hospitalizations in pediatric, internal med-
icine, ear nose throat (ENT), and Intensive Care Unit
(ICU) wards. Hospitalizations and ER visits were consid-
ered bad treatment outcomes. Diagnoses in admission
and/or while visiting the ER could not be obtained, as we
could not be sure that these admissions and/or ER visits
were related to Asthma. However we assume that children
with asthma who receive an adequate pharmaceutical
treatment are less susceptible.
Definition of inappropriate treatment
The Israeli clinical guidelines for drug therapy for child-
hood asthma[25] were translated into a list of six indica-
tors for inadequate treatment defined as "markers" (Table
1). These indicators were agreed by an expert consensus
including pediatricians and respiratory specialists.
Study population
The study population included 6,776 children 3 to 17
years of age insured by CHS in the southern district of
Israel for whom at least two dispensations for asthma
drugs were registered during 1998. Children with other
chronic diseases such as Cystic Fibrosis, or children with
unreasonable drug utilization (10 times the district aver-
age) were excluded.
Validation
In order to ensure that the children who were identified as
eligible for the study do have asthma, we created a rand-
Table 3: Outcomes: mean (standard deviations) for ER visits, hospital admissions and length of stay by marker for the study period (34 
months).
Outcomes With Markers n = 5,498 Without Markers 1,278 n = p
No. of ER visits
Mean 1.5 (3.4) 1.0 (2.2)
Median 1.0 0.00
Min.-Max. 0–30 0–15
Mean Rank 3423.46 3238.10 0.000
No. Hospitalizations
Mean 0.4 (1.5) 0.2 (0.1)
Median 0.00 0.00
Min.-Max. 0–27 0–14
Mean Rank 3406.86 3309.50 0.004
Length of stay (Days)
Mean 1.4 (7.3) 0.7 (3.3)
Median 0.00 0.00
Min.-Max. 0–150 0–54
Mean Rank 3406.70 3310.21 0.005
Table 2: Study population characteristics
n%
Boys 3,919 57.8
Girls 2,857 42.2
Total 6,776 100.0
Median Age 6.0
Mean Age 7.6
S.D 4.0
Range 3–17International Journal of Health Geographics 2006, 5:3 http://www.ij-healthgeographics.com/content/5/1/3
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Map 1: Ditribution of markers Figure 1
Map 1: Ditribution of markers.International Journal of Health Geographics 2006, 5:3 http://www.ij-healthgeographics.com/content/5/1/3
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Map 2: Hospital admissions Figure 2
Map 2: Hospital admissions.International Journal of Health Geographics 2006, 5:3 http://www.ij-healthgeographics.com/content/5/1/3
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Map 3: Emergency room visits Figure 3
Map 3: Emergency room visits.International Journal of Health Geographics 2006, 5:3 http://www.ij-healthgeographics.com/content/5/1/3
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omized sample of 300 families from the study popula-
tion, who were interviewed by phone and were asked if
the child was diagnosed by a physician as having asthma.
Two hundred and seventy-one (90.3%) families agreed to
be interviewed. Two hundred and forty eight families
(91.5%) reported that the child was diagnosed by a phy-
sician as having Asthma.
Constructing the files
Drugs
In order to unify the drug dispensations, we translated
each dispensation into treatment days according to the
recommended dosage. For example: Budicort 50 mcg/1
Inhal = 200 units, (recommendation: 3 times a day) = 65
treatment days.
Health care utilization
Using these files, we computed the number of utilizations
per child during the study period. All data sets were com-
bined into one file where each record, for each child par-
ticipating in the study, included the following variables:
age, sex, affiliated clinic, treatment days for each drug,
number of ER visits, number of hospitalizations and
length of stay, number of GP and specialist visits and
number of imaging tests.
Searching for inappropriate treatment
Using the markers list (Table 1) we electronically searched
the file and marked the subjects who were found to have
one or more markers, and the marker type. For example,
if a record contained 65 days of relievers use without any
use of controller, this record was signed as having "marker
no.1". By the end of the process the system calculated the
frequency of each marker.
GIS mapping
In the first step, we geocoded all study subjects according
to their clinic affiliation. We managed to geocode 100% of
our study population. In the second step, we created the-
matic maps for each study area. Each map describes the
distribution of patients with or without inappropriate
treatment by clinic. Clinics with 10% above the regional
average for inappropriate treatment were "flagged." In the
third step, we mapped the adverse outcomes: emergency
room (ER) visits and hospital admissions, also by clinic
affiliation. These maps describe the distribution of
patients who have or have not visited an ER and were or
were not admitted to a hospital. These maps demonstrate
the association between inappropriate treatment and
adverse outcomes. MapInfo 6.5 software was used for the
GIS mapping.
Statistical Methods
In order to compare ER visits, number of hospitalizations
and length of stay between children with or without mark-
ers for inadequate treatment, and because the means were
not normally distributed, we used a non-parametric, the
Mann Whitney U, test.
Results
6,776 children from 146 CHS clinics were identified as
eligible for participating in the study, their mean age was
7.6 years, 57.8% were boys (Table 2). Eighty-one percent
of the children were found to have at least one marker for
inadequate treatment; 17.5% were found to have more
than one marker. The most common markers were marker
number 5 (high ratio of reliever to controller prescrip-
tions) and marker number 1 (more than 55 days of reliev-
ers treatment without treatment with controllers).
Patients with markers had significantly more ER visits and
hospitalizations, and were hospitalized for a longer
period compared with patients without markers (Table 3).
The results of the GIS mapping show that markers for
inadequate treatment are more prevalent in the clinics
which provide health care services for Bedouin citizens. In
this area, in one-third of the clinics the rate of children
with markers is ten percent higher than the regional aver-
age. In the city of Ashkelon, one-quarter of the clinics had
higher rates of markers than the regional average (Figure
1). Figures 2 and 3 demonstrate the association between
inadequate treatment and adverse outcomes. The same
clinics with a high percentage of markers also have high
percentages of ER visits and hospital admissions.
Discussion
Chronic disease is the major component of the utilization
of health services in developed countries. The increase in
the number of chronic patients in industrialized countries
continues to rise steadily and with it the need of the health
care systems to allocate resources accordingly. One of the
ways in which the priority of resource allocation can be
changed is by improving the standard of care. From this
premise, guidelines and other quality assurance tech-
niques were developed which strive to achieve uniformity
of treatment and constant improvement in its quality,
while decreasing costs.
This study presents a unique model for the management
of a chronic illness using a Geographic Information Sys-
tem (GIS). This model was tested on the management of
childhood asthma in the southern region of Israel. The
motivation behind this study was to respond to the fol-
lowing problems: (1) The rise in asthma morbidity rates
among children and adults for which the treatment is dis-
pensed by family practitioners and specialists; (2) The dif-
ficulties in implementing clinical guidelines; and (3) The
geographic variations in asthma outcomes as documented
world-wide [18-21] and in Israel [26,27]. The maps we
created demonstrate the geographic variations in outcomeInternational Journal of Health Geographics 2006, 5:3 http://www.ij-healthgeographics.com/content/5/1/3
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parameters: ER visits and hospitalization rates, and can be
attributed to the lack of adequate treatment. In other
words, we can see that in those clinics where treatment is
not provided in accordance with the guidelines, the rates
for adverse outcomes are higher.
The information presented by the maps can be also pre-
sented in traditional ways such as tables produced from
sophisticated statistical analyses, but there is no doubt
that these maps are a better way to present the phenom-
ena.
While using GIS technology, it is very important that the
geographic component (e.g., address, zip code, clinic affil-
iation, etc.) in the data base is accurate, otherwise the
geocode process will fail.
The limitation of this model lies in the fact that we used
drug dispensing registries. We used these data to identify
our study population and to identify inadequate treat-
ment. In previous studies [28-30], it was suggested that it
is appropriate to use the drug dispensing data in order to
identify patients in general, as well as for asthma patients
specifically, even if ranking the patients according to the
severity of the disease is required. However, in our study
we do not have information on: [1] whether the patient
actually purchased the medication prescribed by the phy-
sician. There is a possibility that the physician issued a
prescription but the patient decided not to follow the
treatment prescribed. If this bias exists, the practice will
have been misjudged in these cases. We think this bias can
be considered as a very mild one; and, [2] we do not have
information about patients' compliance with the treat-
ment: the patient purchased the drug but did not actually
take it. If this bias exists, we may over-estimate and mis-
judge the treatment outcomes, especially as a result of
inadequate treatment.
A lack of access to health care services is well known as a
predictor of morbidity. In a study like this, accessibility
may play a confounding role especially while examining
malpractice. At this point we should explain that in Israel
we have a national health insurance law and all citizens
are well insured. The accessibility to primary and consult-
ing health care services is very high and does not con-
found our results.
In summary, despite some limitations, we offer here an
efficient tool for analysis of decision making and quality
assurance, which can be implemented in any health
organization for management of any chronic disease.
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